MDT

Medtronic Inc

Stocks

This Stock Could Double by the End of the COVID-19 Pandemic

In China, Spain, Italy, and across the world, we've seen how quickly and easily medical systems can be swamped by big surges in novel coronavirus cases.

In most places here in the United States, healthcare systems have borne up pretty well, though at times, they've been under punishing pressure.

Officials have had to scramble to keep up with demand for care. Among other things, we've seen hotels in New York City pressed into service as hospitals and dormitories for healthcare providers. In Baltimore, the downtown convention center has become a hospital and testing center. In Bayou Segnette State Park, south of New Orleans, even recreational cabins were used as makeshift isolation wards.

That's just some of the improvisation that's had to take place across virtually the entire country.

Technological and medial improvisation has been a recurring theme in some of our talks about the national COVID-19 response.

So today, I want to tell you about a company working to ease the need for such drastic measures. It's not working on a breakthrough vaccine or therapy, or on a lifesaving machine – though its work, in my view, is every bit as important to the fight.

Rather, this company is working on a more, shall we say, basic, foundational approach. And it has a "secret weapon" that can not only help us beat the disease, but has applications and growth potential far beyond healthcare.

Here's what they're up to… Full Story

Here's what they're up to...

Biotechnology

The Incredible Technology Saving Critically Ill COVID-19 Patients

One of the starkest lessons of the global novel coronavirus pandemic is the need for medicine to start looking at existing drugs and procedures in a new way.

We've already seen the benefits of such an approach. The discovery that remdesivir and dexamethasone – an antiviral and a steroid – could both help save severely ill COVID-19 patients' lives springs right to mind.

But adapting the old to fight the new isn't just limited to drugs. Existing medical technology ("medtech") is being used in entirely new ways, or in situations that would've been unthinkable just 10 or 12 months ago.

That's why today I want to talk to you about two compelling companies behind a radical, aggressive therapy that can deliver a "one-two punch" for coronavirus patients who might've otherwise died… Full Story

That's why today I want to talk to you about two compelling companies behind a radical, aggressive therapy that can deliver a "one-two punch" for coronavirus patients who might've otherwise died...

dow jones

Dow Jones Drops 100 Points as Investors Prep for Worst Jobs Report in a Decade

The Dow Jones Industrial Average lost more than 100 points out the gate this morning, investors preparing for higher unemployment levels in the United States.

Yesterday, the Labor Department said that more than 6.3 million people applied for unemployment benefits.

Today, the official jobs report was off in terms of reality.

The official rate jumped from 3.5% to 4.4%.

However, private reports suggest that the real rate is somewhere north of 10%.

Read more...